Marlborough

Marlborough drugmaker Sunovion Pharmaceuticals announced Thursday that clinical tests for its new drug to treat adolescents with schizophrenia is showing positive signs.

Marlborough medical device manufacturer CardioFocus, Inc. announced Thursday it added a new chief commercial officer and a vice president of U.S. sales.

Boston Scientific of Marlborough generated $2.1 billion in sales and $368 million in earnings in its third quarter, the company announced Wednesday.

The president of Telexfree, Inc., a pyramid scheme that was disguised as a Marlborough internet telecom company, pleaded guilty in U.S. District Court in Worcester Monday and forfeited $140 million.

A year after creating a new tourism agency, industry leaders are finding success promoting the region for rowing & swimming, brewery tours, international artists and waterslides.

Marlborough drugmaker Sunovion Pharmaceuticals announced Friday it has purchased a company developing a Parkinson's disease treatment for approximately $635 million.

Research released Tuesday by the Massachusetts Technology Collaborative has found 122 companies making up the state's robotics cluster employed more than 4,700 workers and generated more than $1.6 billion in revenue in 2015.

A Marlborough-based diagnostics company has finalized the purchase of a Massachusetts competitor focused on testing for Lyme disease.

Marlborough's Sunovion has filed a new drug application with the U.S. Food and Drug Administration for ongoing treatment of chronic obstructive pulmonary disease that can make it difficult to breathe.

Marlborough's RXi Pharmaceuticals Corporation has entered into an exclusive agreement to purchase Boston-based MirImmune Inc. and announced plans to raise funds for the purchase.